Genmab A/S

Genmab A/S Net Debt per Share

The Net Debt per Share of Genmab A/S (GMAB.CO) as of Oct 8, 2026 is 9.40 USD. In the previous year, Net Debt per Share was -49.15 USD — a change of -119.11% (higher).

Net Debt per Share

9.40USD

YoY

-119.11%

Last updated:

Net Debt per Share of Genmab A/S is 2025 9.40 USD. Net Debt per Share of Genmab A/S was 2024 -49.15 USD. It decreases by -119.11% higher compared to the previous year.

The Genmab A/S Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2016
-9.45 USD
Jan 1, 2019
-26.42 USD
Jan 1, 2020
-38.59 USD
Jan 1, 2021
-46.32 USD
Jan 1, 2022
-53.21 USD
Jan 1, 2023
-67.01 USD
Jan 1, 2024
-49.15 USD
Jan 1, 2025
9.40 USD
The Genmab A/S Net Debt per Share history
YEARNet Debt per ShareYoY
9.40USD-119.11%
-49.15USD-26.65%
-67.01USD+25.95%
-53.21USD+14.88%
-46.32USD+20.01%
-38.59USD+46.06%
-26.42USD+179.51%
-9.45USD+10.51%
-8.55USD+31.31%
-6.51USD—
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Net Debt per Share of Genmab A/S is 9.40 USD in 2025.

Net Debt per Share of Genmab A/S changed from -49.15 USD to 9.40 USD, representing a -119.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

Other — Genmab A/S

All Key Metrics — Genmab A/S